Professor David Vaccari of Stevens Institute of Technology Receives AEESP Education Award

Dr. David Vaccari, associate professor at Stevens Institute of Technology, has recently been selected by the Association of Environmental Engineering and Science Professors (AEESP) to receive the organization’s 2010 educator award. Sponsored by John Wiley & Sons, Inc., the AEESP Award... - September 04, 2010 - Stevens Institute of Technology

Gene Logic Announces Appointment of Norrie Russell as President

Gene Logic, an Ocimum Biosolutions company announces the appointment of Norrie J. W. Russell, Ph. D., as the President of the company. With more than 30 years of experience in drug discovery, Dr. Russell has a long history of success driving innovation in pharmaceutical discovery and development. He also has experience leading entrepreneurial biotechnology companies, raising capital, and developing pioneering new technologies. - September 04, 2010 - ocimum biosolutions

Ocean Engineering Professor Jon Miller Receives ASCE Educator of the Year Award

American Society of Civil Engineers names Dr. Jon Miller of Stevens Institute of Technology the 2010 Educator of the Year for the North Jersey Branch. - September 02, 2010 - Stevens Institute of Technology

Wireless Networks Enable Intruder Detection and Emergency Alerts Funded by NSF

National Science Foundation funds Dr. Yingying Chen at Stevens Institute of Technology, in collaboration with Dr. Hui Xiong, Rutgers University, in research entitled: "NeTSE:Small:Collaborative Research: MILAN: Multi-Modal Passive Intrusion Learning in Pervasive Wireless Environments." - September 02, 2010 - Stevens Institute of Technology

National Institutes of Health Award a $1.7M SBIR Grant to MicroTransponder to Develop a Neurostimulation-Based Therapy to Treat Tinnitus

MicroTransponder, Inc., a privately-held medical device company, announced that it has been awarded a $1.7M SBIR grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) to develop a neurostimulation-based therapy for the treatment of Tinnitus. This project builds... - September 01, 2010 - MicroTransponder Inc.

AnaSpec Signs Distribution Agreement with Interprise Brasil

AnaSpec, Inc. and Interprise Brasil today announced a non-exclusive distributor agreement that will allow Interprise Brasil to distribute AnaSpec’s catalog and custom products throughout Brasil. - August 28, 2010 - AnaSpec, EGT Group

CW Optics Announces Clinical Trial of Breakthrough Technology for Wound Imaging for Diabetics

CW Optics, Inc. announced today a clinical trial at Richmond's Chippenham and Johnston-Willis (CJW) Medical Center to investigate the safety and efficacy of WoundImager®, an advanced optical imaging device for monitoring the effectiveness of therapeutic management of chronic wounds caused by... - August 27, 2010 - CW Optics, Inc.

CW Optics Announces Clinical Trial of Breakthrough Technology for the Detection of Intravenous Infiltration

CW Optics, Inc. announced today the launch of a clinical trial at the Virginia Commonwealth University Health System to investigate the safety and efficacy of ivWatch®, a novel optical device for monitoring intravenous (IV) infusion sites for infiltration. Each year, there are approximately 150... - August 27, 2010 - CW Optics, Inc.

Bio-Med QC Offers an Indiana Pharmacy Exclusive

Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC

AnaSpec Visits with Noted Alzheimer’s Researcher, Dr. Patrick McGeer

AnaSpec’s general manager, Dr. Anita Hong and technical support specialist, Cecilia Po, visited the highly published and eminent Alzheimer’s researcher, Dr. Patrick McGeer and his associate, Dr. Jian-Ping Guo at the University of British Columbia, Vancouver, Canada on Aug. 12, 2010. - August 22, 2010 - AnaSpec, EGT Group

Strand and Narayana Hrudalaya Collaborate in Translational Cancer Research

First-of-its kind project in translational cancer research aimed to produce pioneering discoveries and affordable clinical solutions in cancer care. - August 21, 2010 - Strand Life Sciences Pvt. Ltd.

The Porcine microRNAome is Revealed

Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC

AnaSpec Introduces SensoLyte® Biotin Quantitation Assay Kit

AnaSpec is pleased to announce the release of the FRET based biotin quantitation kit. The SensoLyte® Biotin Quantitation Assay Kit provides a convenient way to estimate the efficiency of biotinylation for biotin-protein conjugates. The kit also can be used in quantitate biotin concentration in a solution. - August 20, 2010 - AnaSpec, EGT Group

CHI’s BioPharma Strategy Series Presents the Inaugural Mitigating Safety Risks in Early Clinical Development Executive Forum November 8-9, 2010, Philadelphia, PA

Presentations Discuss Bridging the Gap Between Pre-Clinical and Clinical Safety to Improve Prediction. - August 20, 2010 - Cambridge Healthtech Institute

CEO Will Rosellini and MicroTransponder Inc. Named Finalists for the 10th Annual Tech Titans Awards

The MTBC has named CEO Will Rosellini a finalist for the Tech Innovator category and MicroTransponder a finalist for the Emerging Company Horizon category for the 10th Annual Tech Titan Awards in Texas. - August 17, 2010 - MicroTransponder Inc.

Bioo Scientific Chooses Eureka Genomics as Its Next-Generation Sequencing Provider

Bioo Scientific selected Eureka Genomics as its next-generation sequencing service provider. - August 17, 2010 - Bioo Scientific

Clinical Trials in Russia. 2nd Quarter 2010.

The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 178 new clinical trials of all types including local and bioequivalence studies during the second quarter of 2010 demonstrating a 38% increase over the corresponding period of last year. - August 14, 2010 - Synergy Research Group

AnaSpec Introduces Speedy 28-Day Antibody Service

AnaSpec introduces the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds. The first bleed, obtained at the accelerated rate of Day 21 after... - August 11, 2010 - AnaSpec, EGT Group

NSF Funds Innovative Approach to Biomimetic Nanofiber Bone Regeneration

Dr. Hongjun Wang at Stevens Institute of Technology investigates a new bottom-up approach to tissue engineering. - August 06, 2010 - Stevens Institute of Technology

Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2010 BioWest Conference & Expo

The organizers of the annual BioWest Conference & Expo are again looking for the best bioscience start-ups in the region as candidates for this year's $7,500 Dorsey & Whitney Venture Showcase Award. Four companies will be chosen to present at the showcase on Wednesday, September 29, 2010, and will be judged by a panel of venture capitalists. Deadline for entry is Friday, August 20. - August 04, 2010 - Colorado BioScience Association

Novus Biologicals Releases Two New Posters to Guide Antibody Research

Novus revealed two new posters at the ISSCR 8th Annual Meeting between June 16 - 19 – a fluorescent labels poster and a stem cell signalling pathway poster. The fluorescent labels poster displays all fluorophores that Novus offers conjugated to their primary antibodies. The stem cell... - August 04, 2010 - Novus Biologicals Europe

NSF Funds Building a Creativity Collective: Using the Crowd to Solve Societal Problems

Stevens Professors Nickerson and Sakamoto are funded by the National Science Foundation to research crowdsourcing and the creative collective. - July 30, 2010 - Stevens Institute of Technology

International Stem Cell Corporation Planning European Subsidiary

International Stem Cell Corporation (OTCBB:ISCO) announced that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG ('ARG'), a German Investment Fund, to create a new European subsidiary ('ISCO Europe') to be funded with up to $10 million of capital derived from ARG... - July 28, 2010 - International Stem Cell Corporation

ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.

ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010 - ALPCO

Bioo Scientific Releases the ExoMir™ Kit to Facilitate RNA Analysis in Cell-Free Fluids

Bioo Scientific’s new ExoMir™ kit simplifies the fractionation of and RNA extraction from exosomes and other microparticles in cell-free fluids. - July 26, 2010 - Bioo Scientific

Stevens Hosts 2010 Metro Area NEMS/MEMS Workshop

Nanomanufacturing Workshop hosted by Stevens Institute of Technology on Monday, July 26th in Hoboken, New Jersey. - July 24, 2010 - Stevens Institute of Technology

Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform

CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions

AnaSpec’s Published References Pass 1000

As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 1000. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - July 21, 2010 - AnaSpec, EGT Group

ALN Publishes Article on Whole Animal Database by Noesys Data

Article on Artios Software Suite is published by ALN, a respected industry publication covering animal research institutions and markets. - July 21, 2010 - Noesys Data

NSF Funds Infection-Resistant Orthopedic Research

Researchers at Stevens explore inkjet printing of drug-eluting, bioresorbable micropatterns onto the surface of orthopedic implants to prevent bacterial infection of the implants. - July 21, 2010 - Stevens Institute of Technology

Wockhardt Foundation Achieves Another Milestone - Over 200 Cleft Surgeries in Association with Smile Train

Wockhardt Foundation, in collaboration with Smile train has successfully completed over 200 surgeries. - July 18, 2010 - Wockhardt Foundation

200,000 Patients Screened by Wockhardt Foundation Within 200 Days

Wockhardt Foundation screens over 200,000 patients. - July 18, 2010 - Wockhardt Foundation

InnoCore and Nanomi Strengthen Collaboration in Microsphere Technology for Peptide and Protein Delivery

InnoCore Technologies BV and Nanomi BV announce a strategic collaboration for the development of advanced monodisperse biodegradable microsphere-based controlled release formulations for the sustained delivery of biotherapeutics. - July 14, 2010 - Nanomi

International Stem Cell Corp. and India's Largest Eye Hospital to Develop Stem Cell-Based Treatment for Corneal Vision Impairment

International Stem Cell Corporation and Sankara Nethralaya Eye Hospital, a nonprofit medical facility, are collaborating to develop ISCO's 'CytoCor™' stem cell-derived corneal tissue. The goal is to use CytoCor, human tissue derived from pluripotent human stem cells, to treat corneal blindness and vision impairment. - July 11, 2010 - International Stem Cell Corporation

NanoLetters Publishes Dr. Yong Shi’s Energy Harvesting Technology

Dr. Shi’s research focuses on miniature energy harvesting technologies that could potentially power wireless electronics, portable devices, stretchable electronics, and implantable biosensors. - July 11, 2010 - Stevens Institute of Technology

The NIH Awards Aciont® a Small Business Catalyst Award Grant Accelerating Innovative Research

Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®.” - July 08, 2010 - Aciont Inc.

Red Cedar Technology Elects New Board Chairman

Robert Ryan Joins Red Cedar Technology's Leadership Team. - July 02, 2010 - Red Cedar Technology

Wockhardt Foundation Awarded ‘Pharma CSR Organization of the Year 2010’

Wockhardt Foundation wins the CSR award under the leadership of Huzaifa Khorakiwala who through his Human Values has created a team of dedicated warriors to work towards the upliftment of the poor weak and needy. - July 02, 2010 - Wockhardt Foundation

Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America

Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010 - Stemedica Cell Techechnologies

Red Cedar Technology Expands Business Development Team

Angelo Flemings joins Red Cedar Technology as Director of Business Development. - July 02, 2010 - Red Cedar Technology

Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance with Lactagen

Customer Experience Reports indicate relief from the symptoms of lactose intolerance using the Lactagen® program of colonic adaptation. - July 02, 2010 - Lactagen

Colorado BioScience Association Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & Inaugural Class of 'Boettcher Investigators'

Colorado BioScience Association commends Boettcher Foundation on launching the new Webb-Waring Biomedical Research Program and its 2010 (Inaugural) Class of Boettcher Investigators. This new grant program will ensure that the Webb-Waring legacy lives on both through the discovery of new knowledge that improves human health and through the investment in and advancement of early-career scientists. - July 01, 2010 - Colorado BioScience Association

The 5th BIO KOREA 2010, Korea’s Largest Exhibition & Conference, on Biotech in Seoul, 1-3 September

The 5th BIO KOREA 2010 Conference & Exhibition will be held from September 1 to 3, 2010 at COEX in Seoul/Korea. BIO KOREA of this year offers a variety of high-level conference, international exhibition and partnership events and provides an opportunity to find business and technology partners. It expects to 265 companies and about 19,000 visitors from across the globe. - June 29, 2010 - Bio Korea

Functional Genetics Announces Two Separate Awards from the National Institute of Allergy and Infectious Diseases to Develop Broad Spectrum Antivirals

Functional Genetics, Inc. today announced the awarding of two different Phase II SBIR awards from the National Institute of Allergy and Infectious Diseases (NIAID) to pursue innovative approaches for antibody-based targeting of infectious diseases. Under the terms of the agreement, Functional... - June 29, 2010 - Functional Genetics, Inc.

Dr. Mitola and Cognitive Radio Are Featured on Computing Now

Dr. Joseph Mitola III, Vice President for the Research Enterprise at Stevens Institute of Technology, is the subject of a recent article on Computing Now which details the benefits and development of Cognitive Radio (CR), the intelligent wireless technology coined by Dr. Mitola in... - June 25, 2010 - Stevens Institute of Technology

ONR Continues Major Funding of ACCeSS Research Center at Stevens

The Atlantic Center for the Innovative Design and Control of Small Ships (ACCeSS) at Stevens Institute of Technology announced major funding for the next five years worth $4.5 million by the Office of Naval Research (ONR) as part of its National Naval Responsibility – Naval Engineering... - June 24, 2010 - Stevens Institute of Technology

Economic Development Executive Holli Baumunk Named President & CEO of the Colorado BioScience Association Effective July 12

Holli Baumunk, Vice President of the Metro Denver Economic Development Corporation for the past seven years, has been named President & CEO of the Colorado BioScience Association (CBSA) July 12. The announcement is made by Rick Jory, CBSA Board Chairperson, who says Baumunk was unanimously... - June 24, 2010 - Colorado BioScience Association

NSF Funds Mathematical Research at Stevens

Dr. Alexei Miasnikov, Dr. Robert Gilman and Alexander Ushakov of Stevens Institute of Technology were recently awarded NSF funding that enables them to organize the thematic semester on geometric, combinational and computational group theory at the Centre de Recherches Mathmatiques (CRM) in Montreal. - June 23, 2010 - Stevens Institute of Technology

Dr. Mitola Delivered Keynote at CrownCom 2010

On June 9th - 11th 2010, in Cannes, France, Dr. Joseph Mitola III, Vice President for the Research Enterprise at Stevens Institute of Technology, delivered a keynote address at the CrownCom 2010 International Conference on Cognitive Radio Oriented Wireless Networks and Communication. - June 19, 2010 - Stevens Institute of Technology

AnaSpec Introduces New SensoLyte® uPA & tPA Assay Kits

AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. - June 19, 2010 - AnaSpec, EGT Group

Press Releases 2,351 - 2,400 of 3,256